IMMUNOSTIMULANTS (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 169-174, 1993)

被引：65

作者：

HADDEN, JW

机构：

来源：

IMMUNOLOGY TODAY | 1993年 / 14卷 / 06期

关键词：

D O I：

10.1016/0167-5699(93)90045-M

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Nonspecific immunostimulation has progressed from crude microbially derived substances to chemically defined drugs with selective effects on different components of the immune system. John Hadden describes bow immunopharmacological analyses of structure-activity relationships, pharmacokinetics and immunopharmacodynamics have directed the effective use of these agents in disease models and suggest that they may be of value in combination with other therapies in the treatment of immunodeficiencies, cancer, infections and even autoimmune disorders.

引用

页码：275 / 280

页数：6

共 41 条

[1] LEVAMISOLE, THE STORY AND THE LESSONS [J].

AMERY, WKP ;

BRUYNSEELS, JPJM .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (03) :481-486

[2]

AZUMA I, 1992, INT J IMMUNOPHARMACO, V14, P487

[3]

BIZZINI B, 1988, ADV IMMUNOMODULATION

[4] ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].

CARSWELL, EA ;

OLD, LJ ;

KASSEL, RL ;

GREEN, S ;

FIORE, N ;

WILLIAMSON, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670

[5] MISMATCHED DOUBLE-STRANDED-RNA, AMPLIGEN (POLY(I) - POLY(C-12U)), DEMONSTRATES ANTIVIRAL AND IMMUNOSTIMULATORY ACTIVITIES IN HIV DISEASE [J].

CARTER, WA ;

VENTURA, D ;

SHAPIRO, DE ;

STRAYER, DR ;

GILLESPIE, DH ;

HUBBELL, HR .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1991, 13 :69-76

[6]

CHEDID L, 1980, IMMUNOSTIMULATION

[7] ANTIVIRAL EFFICACY OF IMEXON IN THE RAUSCHER MURINE RETROVIRUS AIDS MODEL [J].

CHIRIGOS, MA ;

USSERY, MA ;

RANKIN, JT ;

HERRMANN, D ;

BICKER, U ;

BLACK, PL .

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1990, 12 (01) :1-21

[8]

DESIMONE C, 1992, INT J IMMUNOPHARMACO, V13, P19

[9]

FAVALLI C, 1992, COMBINATION THERAPIES, P275

[10]

FENICHEL RL, 1984, IMMUNE MODULATION AG

← 1 2 3 4 5 →